The client would like to re-engineer a specific HPV vaccine route to market. Therefore, they would like to understand better how to target its communication strategy to increase the vaccine’s uptake among girls 11-14 years old.
About the Client
A major pharmaceutical company is active in the provision of vaccines to combat HPV infection.
While HPV vaccines have been shown to have high efficacy and limited side effects in preventing infection with HPV roots, the vaccination and screening rates remain low. With individual factors (e.g., social and gender norms, procrastination, undervaluation of benefits) playing a decisive role in care-seeking, it is, in the end, essential to identify how the low uptake of vaccination could be reversed by understanding and designing interventions that address both physical and psychological barriers which drive demand and access to HPV vaccines.
Business Consulting Solution
A cross-sectional study evaluating parents’ and general practitioners’ knowledge, attitude, and behavior towards vaccination of children (10-14 years old) against HPV infection was carried out. Notably, the study aimed at:
Identifying caretakers’ and health care professionals’ (HCPs) attitude, future intentions towards vaccination against HPV for themselves and their daughters
Identifying key features and their perceived importance that lead to the decision to choose or refuse vaccination against HPV -e.g., geographical, institutional, and individual factors
Identifying the level of awareness and attitude regarding HPV vaccine administration source, protocols, Gardasil’s safety profile, therapy duration (dosage), and efficacy among HCPs and caretakers
Identifying HCP’s and caretakers’ preferred information and education source and self-perceived unmet needs
The study unveiled the significant issues leading to the low vaccination uptake among boys and girls aged 10-14 years old.